REG - Medica Group PLC - Change of Registered Address

MedicaAnnouncement

08/07/2019 16:40

RNS Number : 8488E
Medica Group PLC
08 July 2019
 


8 July 2019
 
Medica Group Plc
 
Change of Registered Address
 
Medica Group Plc (LSE:MGP), the UK market leader in the provision of teleradiology services, announces that it has changed its registered office address with immediate effect to 6th Floor, One Priory Square, Hastings, East Sussex ,TN34 1EA, United Kingdom.
 
 
 
For further information, please contact:  
 



Medica Group Plc:
Tony Lee
 


+44 (0)20 3727 1000




Investec Bank Plc
Sara Hale
Daniel Adams
 


+44 (0)20 7597 5970




FTI Consulting
Brett Pollard
Victoria Foster Mitchell
Robert Winder
 


+44 (0)20 3727 1000



 
About MEDICA
MEDICA is the UK market leader in the provision of teleradiology services, providing outsourced interpretation and reporting on MRI (magnetic resonance imaging), CT (computerised tomography) and plain film (x-ray) images. The Company currently offers three primary services to hospital radiology departments: NightHawk, an out-of-hours service, routine cross-sectional reporting on MRI and CT scans, and routine plain film reporting on x-ray images.
 
MEDICA has developed a bespoke secure IT platform that provides market-leading linkage between a hospital's Radiology Information System (RIS) and Consultant Radiologists who contract with MEDICA. Direct RIS access ensures that the full wider patient information is available and reviewed with every report.
 
The Company contracts with the largest pool of consultant radiologists outside of the NHS and has been trusted to provide more than 1.3 million examinations annually across its customer base of more than 100 NHS Trusts and various private hospital groups and diagnostic imaging companies. For more information please visit www.medicagroup.co.uk 
 
About Teleradiology
Teleradiology is the electronic transmission of radiological patient images, including plain film (x-rays), CT scans and MRI scans, from one location to another for the purposes of diagnostic interpretation and reporting.




This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
CROLLFVEDRITIIA